Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|June 5, 2003
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Luca Maurillo, et al.
Oncotarget|December 15, 2015
Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damageRoberto Arriga, Sara Caratelli, Andrea Coppola, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2023
Fever of Unknown Origin and Multidrug Resistant Organism Colonization in AML PatientsLuca Guarnera, Gentiana Elena Trotta, Valentina Boldrini, et al.
Leukemia Research and Treatment|June 6, 2013
Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive TherapyChiara Sarlo, Francesco Buccisano, Luca Maurillo, et al.
Cancers|November 26, 2022
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World ExperienceGiovangiacinto Paterno, Raffaele Palmieri, Vittorio Forte, et al.
Haematologica|March 17, 2022
Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trialFrancesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, et al.
Haematologica|May 10, 2007
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrowLuca Maurillo, Francesco Buccisano, Alessandra Spagnoli, et al.
Haematologica|January 28, 2017
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysisSarah A Buckley, Brent L Wood, Megan Othus, et al.
British Journal of Haematology|February 13, 2010
The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemiaGiovanni Del Poeta, Emanuele Ammatuna, Serena Lavorgna, et al.
British Journal of Haematology|April 3, 2004
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemiasFrancesco Buccisano, Francesca Maria Rossi, Adriano Venditti, et al.
Pageof 15